Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia

Middle East respiratory syndrome coronavirus (MERS-CoV) shedding and antibody responses are not fully understood, particularly in relation to underlying medical conditions, clinical manifestations, and mortality.

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas

Research found that vaccination with an adjuvanted Middle East respiratory syndrome (MERS) Spike protein subunit vaccine confers complete protection from MERS disease in alpaca and results in reduced and delayed viral shedding in the upper airways of dromedary camels. Together, these data indicate that induction of robust neutralizing humoral immune responses by vaccination of naïve animals reduces shedding that potentially could diminish the risk of zoonotic transmission.

WHO says two events boosted Saudi hospital MERS outbreak

Nine healthcare workers are among the 39 Middle East respiratory syndrome (MERS) patients identified in a hospital-based outbreak of the virus in Wadi ad-Dawasir, and according to the World Health Organization's (WHO) technical lead the outbreak features both human-to-human transmission patterns and spread from animals.

Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review

The review compiled and analyzed all published data on Middle East respiratory syndrome (MERS) in the global camel population to provide an overview of current knowledge on the distribution, spread and risk factors of infections in dromedary camels.